Efavirenz reclassified as FDA pregnancy category D.

PubWeight™: 1.01^‹?› | Rank: Top 15%

🔗 View Article (PMID 15754452)

Published in AIDS Clin Care on February 01, 2005

Authors

Lynne M Mofenson¹

Author Affiliations

1: Pediatric, Adolescent and Maternal AIDS Branch, National Institute of Child Health and Human Development, NIH, Bethesda, Maryland, USA.

Articles citing this ↘

HIV and pregnancy. BMJ (2007) 1.90

Efavirenz use during pregnancy and for women of child-bearing potential. AIDS Res Ther (2006) 0.81

First trimester exposure to antiretroviral therapy and risk of birth defects. Pediatr Infect Dis J (2014) 0.80

German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008. Eur J Med Res (2009) 0.78